Derma Sciences (DSCI) Reports In-Line Q3 EPS

November 10, 2016 8:21 AM EST

Find out which companies are about to raise their dividend well before the news hits the Street with's Dividend Insider Elite. Sign-up for a FREE trial here.

Derma Sciences (NASDAQ: DSCI) reported Q3 EPS of ($0.04), in-line with the analyst estimate of ($0.04). Revenue for the quarter came in at $21.8 million versus the consensus estimate of $23.9 million.


Derma Sciences sees FY2016 revenue of $81.6 million, versus the consensus of $92.4 million.

For earnings history and earnings-related data on Derma Sciences (DSCI) click here.

Serious News for Serious Traders! Try Premium Free!

You May Also Be Interested In

Related Categories

Earnings, Guidance

Related Entities


Add Your Comment